The information on this page is for informational purposes only and does not constitute medical advice. Consult your genetic counselor or specialist physician for treatment decisions.

F9

—Coagulation Factor IX

Chromosome: X

Location: X:139530731-139568549

OMIM: 300746

Ensembl: ENSG00000101981

Official·OMIM:300746 Official·ENSG00000101981

Encodes coagulation factor IX. Mutations cause Hemophilia B.

Treatment Roadmap — F9

FDA Approved

Preclinical

Phase 1

Phase 2

Phase 3

Approved

Hemgenix (etranacogene dezaparvovec) — FDA (11/22/2022)

Clinical trials have approximately 10% success rate. This roadmap shows the current status, not guaranteed outcomes.

Associated Diseases

Hemophilia B

X-Linked RecessivePrevalence: ~30Khematologic

Official·OMIM:306900 Official·ORPHA101

Summary

Clinical Trial

Approved Therapy

Registered Variant

F9

Treatment Roadmap — F9

Associated Diseases

Summary

Approved Therapies